Women's Health Initiative (WHI)

Clinical Trial ID NCT00000611

PubWeight™ 535.42‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00000611

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002 80.37
2 Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004 23.69
3 Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006 12.44
4 Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006 12.09
5 Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003 11.39
6 Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. JAMA 2003 10.61
7 Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007 10.50
8 Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006 8.73
9 Estrogen therapy and coronary-artery calcification. N Engl J Med 2007 8.70
10 Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol 2003 8.64
11 Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 2002 7.77
12 Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA 2013 7.19
13 Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010 7.12
14 Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc 2005 6.73
15 Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006 6.51
16 Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA 2006 5.75
17 Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002 5.73
18 Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med 2004 5.65
19 Effects of estrogen with and without progestin on urinary incontinence. JAMA 2005 5.41
20 Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004 5.35
21 Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003 5.26
22 Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet 2009 5.22
23 The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 2012 4.87
24 Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003 4.83
25 Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol 2005 4.55
26 Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA 2008 4.42
27 Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med 2010 4.27
28 Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005 4.24
29 Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA 2003 4.07
30 Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003 4.03
31 Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011 3.85
32 Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004 3.85
33 Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. JAMA Oncol 2015 3.64
34 Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol 2012 3.56
35 Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 2004 3.53
36 Estrogen plus progestin and risk of venous thrombosis. JAMA 2004 3.46
37 Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause 2004 3.33
38 Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006 3.29
39 Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002 3.27
40 Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 2002 3.01
41 Sexual orientation and health: comparisons in the women's health initiative sample. Arch Fam Med 2000 2.97
42 Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006 2.97
43 Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA 2003 2.90
44 Association between cardiovascular outcomes and antihypertensive drug treatment in older women. JAMA 2004 2.90
45 Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials. Arch Intern Med 2010 2.89
46 Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care 2008 2.76
47 The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Ann Epidemiol 2003 2.64
48 Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004 2.63
49 Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Arch Intern Med 2009 2.54
50 Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause 2010 2.50
51 Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative. Cancer Res 2003 2.49
52 Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation 2005 2.49
53 Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study. Neurology 2009 2.45
54 Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 2011 2.44
55 Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. Am J Clin Nutr 2010 2.43
56 The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000 2.40
57 Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. J Natl Cancer Inst 2007 2.37
58 Symptom experience after discontinuing use of estrogen plus progestin. JAMA 2005 2.32
59 Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr 2011 2.21
60 Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Arch Intern Med 2005 2.17
61 Aspirin is associated with lower melanoma risk among postmenopausal Caucasian women: the Women's Health Initiative. Cancer 2013 2.14
62 Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative. Arthritis Rheumatol 2015 2.07
63 Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers. Am J Epidemiol 2011 2.04
64 Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci 2009 2.01
65 Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Obstet Gynecol 2005 2.01
66 Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause 2010 2.00
67 Resting heart rate as a low tech predictor of coronary events in women: prospective cohort study. BMJ 2009 1.99
68 Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. Am J Epidemiol 2009 1.98
69 Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Arch Intern Med 2008 1.94
70 Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med 2008 1.89
71 Fracture risk among breast cancer survivors: results from the Women's Health Initiative Observational Study. Arch Intern Med 2005 1.85
72 Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. Am J Epidemiol 2005 1.83
73 Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study. Ann Intern Med 2003 1.81
74 Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum 2008 1.80
75 Hypertension and its treatment in postmenopausal women: baseline data from the Women's Health Initiative. Hypertension 2000 1.77
76 Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit. Fertil Steril 2005 1.72
77 The WHI estrogen-alone trial--do things look any better? JAMA 2004 1.64
78 Magnesium intake, bone mineral density, and fractures: results from the Women's Health Initiative Observational Study. Am J Clin Nutr 2014 1.60
79 Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Med 2011 1.55
80 Can biomarkers identify women at increased stroke risk? The Women's Health Initiative Hormone Trials. PLoS Clin Trials 2007 1.54
81 Coronary artery calcification in black women and white women. Am Heart J 2003 1.52
82 Baseline age and time to major fracture in younger postmenopausal women. Menopause 2015 1.49
83 Diet quality and the risk of cardiovascular disease: the Women's Health Initiative (WHI). Am J Clin Nutr 2011 1.48
84 Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA 2007 1.47
85 Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiol Biomarkers Prev 2009 1.46
86 The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trials. J Hypertens 2014 1.45
87 Special populations recruitment for the Women's Health Initiative: successes and limitations. Control Clin Trials 2004 1.43
88 Use of Medicare data to identify coronary heart disease outcomes in the Women's Health Initiative. Circ Cardiovasc Qual Outcomes 2014 1.41
89 Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. JAMA 2017 1.40
90 Bone mineral density of American Indian and Alaska Native women compared with non-Hispanic white women: results from the Women's Health Initiative Study. Menopause 2005 1.40
91 Biomarker-calibrated energy and protein consumption and cardiovascular disease risk among postmenopausal women. Epidemiology 2011 1.37
92 Physical activity and diabetes risk in postmenopausal women. Am J Prev Med 2005 1.36
93 Effect of estrogen therapy on gallbladder disease. JAMA 2005 1.36
94 Recruitment of Hispanic women to the Women's Health Initiative. the case of Embajadoras in Arizona. Control Clin Trials 2002 1.35
95 Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med 2008 1.34
96 Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI Study. Neurology 2009 1.32
97 Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. Am J Clin Nutr 2011 1.31
98 Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Cancer Epidemiol Biomarkers Prev 2009 1.29
99 Failure of estrogen plus progestin therapy for prevention. JAMA 2002 1.26
100 Mediterranean and DASH diet scores and mortality in women with heart failure: The Women's Health Initiative. Circ Heart Fail 2013 1.24
Next 100